North America Uterine Fibroid Treatment Device Market Size & Outlook, 2027

Revenue, 2020 (US$M)

$2,877.3

Forecast, 2027 (US$M)

$5,283.4

CAGR, 2021 - 2027

9.1%

Report Coverage

North America

North America uterine fibroid treatment device market, 2016-2027 (US$M)

Related Markets

Global Uterine Fibroid Treatment Device Industry

U.S. Uterine Fibroid Treatment Device Market Outlook

Canada Uterine Fibroid Treatment Device Market Outlook

Europe Uterine Fibroid Treatment Device Market Outlook

Germany Uterine Fibroid Treatment Device Market Outlook

France Uterine Fibroid Treatment Device Market Outlook

Italy Uterine Fibroid Treatment Device Market Outlook

Spain Uterine Fibroid Treatment Device Market Outlook

UK Uterine Fibroid Treatment Device Market Outlook

Asia Pacific Uterine Fibroid Treatment Device Market Outlook

Japan Uterine Fibroid Treatment Device Market Outlook

China Uterine Fibroid Treatment Device Market Outlook

India Uterine Fibroid Treatment Device Market Outlook

Australia Uterine Fibroid Treatment Device Market Outlook

South Korea Uterine Fibroid Treatment Device Market Outlook

Latin America Uterine Fibroid Treatment Device Market Outlook

Mexico Uterine Fibroid Treatment Device Market Outlook

Argentina Uterine Fibroid Treatment Device Market Outlook

Colombia Uterine Fibroid Treatment Device Market Outlook

Brazil Uterine Fibroid Treatment Device Market Outlook

MEA Uterine Fibroid Treatment Device Market Outlook

South Africa Uterine Fibroid Treatment Device Market Outlook

Saudi Arabia Uterine Fibroid Treatment Device Market Outlook

UAE Uterine Fibroid Treatment Device Market Outlook

North America uterine fibroid treatment device market highlights

The North America uterine fibroid treatment device market generated a revenue of USD 2,877.3 million in 2020.
The market is expected to grow at a CAGR of 9.1% from 2021 to 2027.
In terms of segment, surgical technologies was the largest revenue generating technology in 2020.
Ablation Techniques is the most lucrative technology segment registering the fastest growth during the forecast period.
Country-wise, Canada is expected to register the highest CAGR from 2021 to 2027.

North America data book summary

Market revenue in 2020	USD 2,877.3 million
Market revenue in 2027	USD 5,283.4 million
Growth rate	9.1% (CAGR from 2020 to 2027)
Largest segment	Surgical technologies
Fastest growing segment	Ablation Techniques
Historical data covered	2016 - 2019
Base year for estimation	2020
Forecast period covered	2021 - 2027
Quantitative units	Revenue in USD million
Market segmentation	Surgical Technologies, Ablation Techniques, Laparoscopic Techniques, Embolization Techniques
Key market players worldwide	Medtronic PLC, Boston Scientific Corp, Stryker Corp, CooperSurgical, Hologic Inc, Lumenis, InSightec

Other key industry trends

In terms of revenue, North America region accounted for 58.0% of the global uterine fibroid treatment device market in 2020.
Globally, North America is projected to lead the regional market in terms of revenue in 2027.
Asia Pacific is the fastest growing regional market and is projected to reach USD 1,203.7 million by 2027.

Key Regions: U.S. , UK , Japan , Brazil , UAE

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Uterine Fibroid Treatment Device Market Scope

Uterine fibroid treatment device market segmentation & scope

Uterine Fibroid Treatment Device Market Companies

Name	Profile	# Employees	HQ	Website

North America uterine fibroid treatment device market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to uterine fibroid treatment device market will help companies and investors design strategic landscapes.

Surgical technologies was the largest segment with a revenue share of 31.3% in 2020. Horizon Databook has segmented the North America uterine fibroid treatment device market based on surgical technologies, ablation techniques, laparoscopic techniques, embolization techniques covering the revenue growth of each sub-segment from 2016 to 2027.

North America Uterine Fibroid Treatment Device Technology Outlook (Revenue, USD Million, 2016-2027)
- Surgical Technologies
  - Hysterectomy
  - Myomectomy
- Ablation Techniques
  - Microwave Ablation
  - Hydrothermal Ablation
  - Cryoablation
  - Ultrasound Ablation
    - High Intensity Focused Ultrasound (HIFU)
    - MRI-guided Focused Ultrasound (MRgFUS)
- Laparoscopic Techniques
  - Laparoscopic Myotectomy
  - Myolysis
- Embolization Techniques
North America Uterine Fibroid Treatment Device Mode of Treatment Outlook (Revenue, USD Million, 2016-2027)
- Invasive Treatment
- Minimally Invasive Treatment
- Non-invasive Treatment

Reasons to subscribe to North America uterine fibroid treatment device market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America uterine fibroid treatment device market databook

Our clientele includes a mix of uterine fibroid treatment device market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America uterine fibroid treatment device market, including forecasts for subscribers. This continent databook contains high-level insights into North America uterine fibroid treatment device market from 2016 to 2027, including revenue numbers, major trends, and company profiles.